Business
Medical Marijuana, Inc. Subsidiary HempMeds® Brasil Applauds ANVISA's New Regulations of Medical Cannabis Products in Brazil
Medical Marijuana, Inc. Subsidiary HempMeds® Brasil Applauds ANVISA's New Regulations of Medical Cannabis Products in Brazil.
About this update from Medical Marijuana, Inc.
[{"type":"text","content":"\n\n\n\nMedical Marijuana, Inc. Subsidiary HempMeds® Brasil Applauds ANVISA's New Regulations of Medical Cannabis Products in Brazil\n\n/* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n\n\n\n\n\n\nMedical Marijuana, Inc. Subsidiary HempMeds® Brasil Applauds ANVISA's New Regulations of Medical Cannabis Products in Brazil\nPR Newswire\nSAN DIEGO, Dec. 5, 2019\n\n\n\nSAN DIEGO, Dec. 5, 2019 /PRNewswire/ -- Medical Marijuana, Inc. (\"the Company\") (OTC: MJNA), the first-ever publicly traded cannabis company in the United States that launched the world's first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that subsidiary HempMeds® Brasil applauds ANVISA (the National Agency for Health Supervision) for unanimously approving the regulation of medical marijuana to be sold at pharmacies and drugstores nationwide. Brazil's new regulations will be published soon on the Federal Official Gazette and entered into law 90 days after that.\n\"These new regulations to allow the rollout of cannabis products in pharmacies and drugstores create a new category of medicinal cannabis products in Brazil,\" said HempMeds® Brasil Vice President Caroline Heinz. \"This change will allow patients almost immediate access to CBD products – a huge difference from today where the process takes three months. The approximate four million patients in Brazil can benefit from medical cannabis much easier with the ability to visit their doctor's office and go directly to a pharmacy. We hope that this will encourage more people to see how cannabis could help improve their health and wellness.\"\nCurrently, patients in Brazil must request the importation of cannabidiol (CBD) products through the federal government website. The process involves attaching a report explaining the patient's need, which must be signed off by their doctor, to a prescription liability statement. These new regulations will allow CBD and tetrahydrocannabinol (THC) products to be available at pharmacies and drugstores with a prescription and set guidelines for the manufact...